Oxitropium Bromide

氧托溴铵

Report date: 2026/03/23 20:03:44
NME

Base Information

Drug NameOxitropium Bromide
Drug Alias Name溴化氧托品OxiventTersiganBA-253
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1983/01/01
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. Kg
Active IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Inactive IndicationsN/A

Other Information

ATC CodeR03BB02
Related LinksWikipediaKEGG